BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
FABP1
,
nitric oxide metabolic process
,
Hepatitis
,
Kidney
,
Biofuel
,
Lipopolysaccharide
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
lymphoma b- cell
NextBio Summary
General Info
Curated Studies
Most Correlated Studies
Lymphoma (4 types) and B-cell purified subpopulation gene expression profiling
Canine lymphomas analyzed by breed and subtype
Diffuse large B cell lymphoma SU-DHL-6, SU-DHL-4 and Farage cells treated with BCL6 inhibitor FX1
Diffuse large B cell lymphoma cell lines treated with BCL6-inhibitor 79-6.1085
Diffuse large B cell lymphoma cells with or without BET Bromodomain inhibitor OTX015 treatment
Explore Curated Studies Results
Literature
Most Relevant Literature
CAR T-cell therapy for B-cell lymphoma.
Bendamustine-induced rash is associated with a favorable prognosis in patients with indolent B-cell …
Targeting the tumor microenvironment in B-cell lymphoma: challenges and opportunities.
Development of molecular intervention strategies for B-cell lymphoma.
HCV-related lymphoproliferative disorders in the direct-acting antiviral era: From mixed cryoglobuli…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Single-Cell Map of Immune and Lymphoma Cells in B-cell Non-Hodgkin's Lymphoma
CD19 CAR-T Cell Therapy for Relapsed/Refractory B-cell Lymphoma and B-cell Acute Lymphoblastic Leuke…
Multiple Fields Radiotherapy Versus Intravenous Rituximab in the Treatment of Indolent Cutaneous Lym…
Alisertib, Bortezomib, and Rituximab in Treating Patients With Relapsed or Refractory Mantle Cell Ly…
Anti-CD19 CAR in PiggyBac Transposon-Engineered T Cells for Relapsed/Refractory B-cell Lymphoma or B…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ